|
2008-02-25 |
2008-02-21 |
S
Sale
|
Rubenstein James H
Medical Director
Executive Director
Large shareholder
|
2,651
-10.4%
210.13
US$363,184
|
2,651
-10.4%
|
210.13
|
US$363,184
|
|
|
2008-02-25 |
2008-02-21 |
S
Sale
|
Rubenstein James H
Medical Director
Executive Director
Large shareholder
|
19,130
-33.0%
452.15
US$4,984,498
|
19,130
-33.0%
|
452.15
|
US$4,984,498
|
|
|
2008-02-25 |
2008-02-21 |
S
Sale
|
Dosoretz Daniel E
Chief Executive Officer
Executive Director
Large shareholder
|
14,346
+47.8%
473.11
US$3,610,379
|
14,346
+47.8%
|
473.11
|
US$3,610,379
|
|
|
2008-02-25 |
2008-02-21 |
S
Sale
|
Dosoretz Daniel E
Chief Executive Officer
Executive Director
Large shareholder
|
1,637,216
-100.0%
32.50
US$53,209,520
|
1,637,216
-100.0%
|
32.50
|
US$53,209,520
|
|
|
2008-02-25 |
2008-02-21 |
S
Sale
|
Dosoretz Daniel E
Chief Executive Officer
Executive Director
Large shareholder
|
1,307,693
-100.0%
32.50
US$42,500,022
|
1,307,693
-100.0%
|
32.50
|
US$42,500,022
|
|
|
2008-02-25 |
2008-02-21 |
S
Sale
|
Katin Michael J
Non-Executive Director
|
66,896
-100.0%
32.50
US$2,174,120
|
66,896
-100.0%
|
32.50
|
US$2,174,120
|
|
|
2008-02-25 |
2008-02-21 |
S
Sale
|
Katin Michael J
Non-Executive Director
|
492,308
-100.0%
32.50
US$16,000,010
|
492,308
-100.0%
|
32.50
|
US$16,000,010
|
|
|
2008-02-25 |
2008-02-21 |
S
Sale
|
Sheridan Howard M
Chairman of the Board
Executive Director
|
50,000
-100.0%
32.50
US$1,625,000
|
50,000
-100.0%
|
32.50
|
US$1,625,000
|
|
|
2008-02-25 |
2008-02-21 |
S
Sale
|
Sheridan Howard M
Chairman of the Board
Executive Director
|
296,154
-100.0%
32.50
US$9,625,005
|
296,154
-100.0%
|
32.50
|
US$9,625,005
|
|
|
2008-02-25 |
2008-02-21 |
S
Sale
|
Sheridan Howard M
Chairman of the Board
Executive Director
|
809,425
-100.0%
32.50
US$26,306,312
|
809,425
-100.0%
|
32.50
|
US$26,306,312
|
|
|
2008-02-25 |
2008-02-21 |
S
Sale
|
WATSON DAVID N T
Executive VP and CFO
Officer
|
14,711
-100.0%
32.50
US$478,108
|
14,711
-100.0%
|
32.50
|
US$478,108
|
|
|
2008-02-25 |
2008-02-21 |
S
Sale
|
Inge Ronald E
Non-Executive Director
|
5,000
-100.0%
32.50
US$162,500
|
5,000
-100.0%
|
32.50
|
US$162,500
|
|
|
2008-02-25 |
2008-02-21 |
S
Sale
|
Dorsett Herbert F
Non-Executive Director
|
200
-100.0%
32.50
US$6,500
|
200
-100.0%
|
32.50
|
US$6,500
|
|
|
2008-02-25 |
2008-02-21 |
S
Sale
|
Rubenstein James H
Medical Director
Executive Director
Large shareholder
|
1,125,595
-100.0%
32.50
US$36,581,838
|
1,125,595
-100.0%
|
32.50
|
US$36,581,838
|
|
|
2008-02-25 |
2008-02-21 |
S
Sale
|
Agin Solomon
Non-Executive Director
|
120
-100.0%
32.50
US$3,900
|
120
-100.0%
|
32.50
|
US$3,900
|
|
|
2008-02-25 |
2008-02-21 |
S
Sale
|
Doerr Leo
Non-Executive Director
|
2,500
-100.0%
32.50
US$81,250
|
2,500
-100.0%
|
32.50
|
US$81,250
|
|
|
2008-02-25 |
2008-02-21 |
S
Sale
|
Dosoretz Daniel E
Chief Executive Officer
Executive Director
Large shareholder
|
875,195
-100.0%
32.50
US$28,443,838
|
875,195
-100.0%
|
32.50
|
US$28,443,838
|
|
|
2008-02-25 |
2008-02-21 |
S
Sale
|
Katin Michael J
Non-Executive Director
|
535,901
-100.0%
32.50
US$17,416,782
|
535,901
-100.0%
|
32.50
|
US$17,416,782
|
|
|
2008-02-25 |
2008-02-21 |
S
Sale
|
Sheridan Howard M
Chairman of the Board
Executive Director
|
1,105,580
-100.0%
32.50
US$35,931,350
|
1,105,580
-100.0%
|
32.50
|
US$35,931,350
|
|
|
2007-06-11 |
2007-06-07 |
B
Purchase
|
Agin Solomon
Non-Executive Director
|
10
+9.1%
26.27
US$263
|
10
+9.1%
|
26.27
|
US$263
|
|
|
2007-05-24 |
2007-05-24 |
PlS
Planned sale
|
Dosoretz Daniel E
Chief Executive Officer
Executive Director
Large shareholder
|
10,000
-0.6%
26.84
US$268,412
|
10,000
-0.6%
|
26.84
|
US$268,412
|
|
|
2007-05-24 |
2007-05-24 |
PlS
Planned sale
|
Rubenstein James H
Medical Director
Executive Director
Large shareholder
|
10,000
-1.0%
26.84
US$268,412
|
10,000
-1.0%
|
26.84
|
US$268,412
|
|
|
2007-05-24 |
2007-05-23 |
PlS
Planned sale
|
Dosoretz Daniel E
Chief Executive Officer
Executive Director
Large shareholder
|
9,200
-0.5%
26.90
US$247,480
|
9,200
-0.5%
|
26.90
|
US$247,480
|
|
|
2007-05-24 |
2007-05-23 |
PlS
Planned sale
|
Rubenstein James H
Medical Director
Executive Director
Large shareholder
|
9,200
-0.9%
26.90
US$247,480
|
9,200
-0.9%
|
26.90
|
US$247,480
|
|
|
2007-05-24 |
2007-05-22 |
PlS
Planned sale
|
Dosoretz Daniel E
Chief Executive Officer
Executive Director
Large shareholder
|
800
-0.0%
27.00
US$21,600
|
800
-0.0%
|
27.00
|
US$21,600
|
|
|
2007-05-24 |
2007-05-22 |
PlS
Planned sale
|
Rubenstein James H
Medical Director
Executive Director
Large shareholder
|
800
-0.1%
27.00
US$21,600
|
800
-0.1%
|
27.00
|
US$21,600
|
|
|
2007-05-09 |
2007-05-09 |
B
Purchase
|
Doerr Leo
Non-Executive Director
|
600
+31.6%
28.38
US$17,028
|
600
+31.6%
|
28.38
|
US$17,028
|
|
|
2007-05-09 |
2007-05-08 |
B
Purchase
|
Doerr Leo
Non-Executive Director
|
1,900
+inf%
28.45
US$54,048
|
1,900
+inf%
|
28.45
|
US$54,048
|
|
|
2007-04-26 |
2007-04-24 |
PlS
Planned sale
|
Rubenstein James H
Medical Director
Executive Director
Large shareholder
|
20,000
-1.9%
29.00
US$580,098
|
20,000
-1.9%
|
29.00
|
US$580,098
|
|
|
2007-04-26 |
2007-04-24 |
PlS
Planned sale
|
Dosoretz Daniel E
Chief Executive Officer
Executive Director
Large shareholder
|
20,000
-1.1%
29.00
US$580,098
|
20,000
-1.1%
|
29.00
|
US$580,098
|
|
|
2007-03-12 |
2007-03-08 |
PlS
Planned sale
|
Dosoretz Daniel E
Chief Executive Officer
Executive Director
Large shareholder
|
20,000
-1.1%
30.00
US$600,000
|
20,000
-1.1%
|
30.00
|
US$600,000
|
|
|
2007-03-12 |
2007-03-08 |
PlS
Planned sale
|
Rubenstein James H
Medical Director
Executive Director
Large shareholder
|
20,000
-1.8%
30.00
US$600,000
|
20,000
-1.8%
|
30.00
|
US$600,000
|
|
|
2007-03-05 |
2007-02-28 |
B
Purchase
|
Agin Solomon
Non-Executive Director
|
10
+10.0%
30.00
US$300
|
10
+10.0%
|
30.00
|
US$300
|
|
|
2007-02-13 |
2007-02-12 |
PlS
Planned sale
|
Dosoretz Daniel E
Chief Executive Officer
Executive Director
Large shareholder
|
10,050
-0.6%
32.00
US$321,600
|
10,050
-0.6%
|
32.00
|
US$321,600
|
|
|
2007-02-13 |
2007-02-12 |
PlS
Planned sale
|
Rubenstein James H
Medical Director
Executive Director
Large shareholder
|
10,050
-0.9%
32.00
US$321,600
|
10,050
-0.9%
|
32.00
|
US$321,600
|
|
|
2007-02-08 |
2007-02-06 |
PlS
Planned sale
|
Dosoretz Daniel E
Chief Executive Officer
Executive Director
Large shareholder
|
9,950
-0.6%
32.28
US$321,160
|
9,950
-0.6%
|
32.28
|
US$321,160
|
|
|
2007-02-08 |
2007-02-06 |
PlS
Planned sale
|
Rubenstein James H
Medical Director
Executive Director
Large shareholder
|
9,950
-0.9%
32.28
US$321,160
|
9,950
-0.9%
|
32.28
|
US$321,160
|
|
|
2007-01-12 |
2007-01-11 |
PlS
Planned sale
|
Rubenstein James H
Medical Director
Executive Director
Large shareholder
|
10,000
-0.9%
32.25
US$322,500
|
10,000
-0.9%
|
32.25
|
US$322,500
|
|
|
2007-01-12 |
2007-01-11 |
PlS
Planned sale
|
Dosoretz Daniel E
Chief Executive Officer
Executive Director
Large shareholder
|
10,000
-0.6%
32.25
US$322,500
|
10,000
-0.6%
|
32.25
|
US$322,500
|
|
|
2007-01-12 |
2007-01-10 |
PlS
Planned sale
|
Rubenstein James H
Medical Director
Executive Director
Large shareholder
|
10,000
-0.9%
31.98
US$319,755
|
10,000
-0.9%
|
31.98
|
US$319,755
|
|
|
2007-01-12 |
2007-01-10 |
PlS
Planned sale
|
Dosoretz Daniel E
Chief Executive Officer
Executive Director
Large shareholder
|
10,000
-0.6%
31.98
US$319,755
|
10,000
-0.6%
|
31.98
|
US$319,755
|
|
|
2006-12-14 |
2006-12-14 |
PlS
Planned sale
|
Dosoretz Daniel E
Chief Executive Officer
Executive Director
Large shareholder
|
5,000
-0.3%
32.44
US$162,188
|
5,000
-0.3%
|
32.44
|
US$162,188
|
|
|
2006-12-14 |
2006-12-14 |
PlS
Planned sale
|
Rubenstein James H
Medical Director
Executive Director
Large shareholder
|
5,000
-0.4%
32.44
US$162,188
|
5,000
-0.4%
|
32.44
|
US$162,188
|
|
|
2006-12-14 |
2006-12-13 |
PlS
Planned sale
|
Dosoretz Daniel E
Chief Executive Officer
Executive Director
Large shareholder
|
14,200
-0.8%
32.34
US$459,190
|
14,200
-0.8%
|
32.34
|
US$459,190
|
|
|
2006-12-14 |
2006-12-13 |
PlS
Planned sale
|
Rubenstein James H
Medical Director
Executive Director
Large shareholder
|
14,200
-1.2%
32.34
US$459,190
|
14,200
-1.2%
|
32.34
|
US$459,190
|
|
|
2006-12-14 |
2006-12-12 |
PlS
Planned sale
|
Dosoretz Daniel E
Chief Executive Officer
Executive Director
Large shareholder
|
800
-0.0%
32.26
US$25,811
|
800
-0.0%
|
32.26
|
US$25,811
|
|
|
2006-12-14 |
2006-12-12 |
PlS
Planned sale
|
Rubenstein James H
Medical Director
Executive Director
Large shareholder
|
800
-0.1%
32.26
US$25,811
|
800
-0.1%
|
32.26
|
US$25,811
|
|
|
2006-12-07 |
2006-12-06 |
PlS
Planned sale
|
KOENINGER DAVID M
Chief Financial Officer
Officer
|
35,000
-25.0%
32.81
US$1,148,518
|
35,000
-25.0%
|
32.81
|
US$1,148,518
|
|
|
2006-11-30 |
2006-11-28 |
B
Purchase
|
Agin Solomon
Non-Executive Director
|
15
+17.6%
33.60
US$504
|
15
+17.6%
|
33.60
|
US$504
|
|
|
2006-11-28 |
2006-11-27 |
PlS
Planned sale
|
Biscardi Joseph
Corporate Controller
Officer
|
23,100
-100.0%
33.71
US$778,595
|
23,100
-100.0%
|
33.71
|
US$778,595
|
|
|
2006-11-28 |
2006-11-24 |
PlS
Planned sale
|
Biscardi Joseph
Corporate Controller
Officer
|
6,900
-100.0%
34.00
US$234,634
|
6,900
-100.0%
|
34.00
|
US$234,634
|
|
|
2006-11-06 |
2006-11-03 |
PlS
Planned sale
|
Dosoretz Daniel E
Chief Executive Officer
Executive Director
Large shareholder
|
10,000
-0.5%
30.97
US$309,696
|
10,000
-0.5%
|
30.97
|
US$309,696
|
|
|
2006-11-06 |
2006-11-03 |
PlS
Planned sale
|
Rubenstein James H
Medical Director
Executive Director
Large shareholder
|
10,000
-0.9%
30.97
US$309,696
|
10,000
-0.9%
|
30.97
|
US$309,696
|
|
|
2006-11-06 |
2006-11-02 |
PlS
Planned sale
|
Dosoretz Daniel E
Chief Executive Officer
Executive Director
Large shareholder
|
10,000
-0.5%
30.52
US$305,243
|
10,000
-0.5%
|
30.52
|
US$305,243
|
|
|
2006-11-06 |
2006-11-02 |
PlS
Planned sale
|
Rubenstein James H
Medical Director
Executive Director
Large shareholder
|
10,000
-0.9%
30.52
US$305,243
|
10,000
-0.9%
|
30.52
|
US$305,243
|
|
|
2006-10-10 |
2006-10-10 |
PlS
Planned sale
|
Dosoretz Daniel E
Chief Executive Officer
Executive Director
Large shareholder
|
10,000
-0.5%
30.71
US$307,100
|
10,000
-0.5%
|
30.71
|
US$307,100
|
|
|
2006-10-10 |
2006-10-10 |
PlS
Planned sale
|
Rubenstein James H
Medical Director
Executive Director
Large shareholder
|
10,000
-0.8%
30.71
US$307,100
|
10,000
-0.8%
|
30.71
|
US$307,100
|
|
|
2006-10-10 |
2006-10-09 |
PlS
Planned sale
|
Dosoretz Daniel E
Chief Executive Officer
Executive Director
Large shareholder
|
1,400
-0.1%
30.00
US$42,000
|
1,400
-0.1%
|
30.00
|
US$42,000
|
|
|
2006-10-10 |
2006-10-09 |
PlS
Planned sale
|
Rubenstein James H
Medical Director
Executive Director
Large shareholder
|
1,400
-0.1%
30.00
US$42,000
|
1,400
-0.1%
|
30.00
|
US$42,000
|
|
|
2006-10-10 |
2006-10-06 |
PlS
Planned sale
|
Dosoretz Daniel E
Chief Executive Officer
Executive Director
Large shareholder
|
3,100
-0.2%
30.00
US$93,000
|
3,100
-0.2%
|
30.00
|
US$93,000
|
|
|
2006-10-10 |
2006-10-06 |
PlS
Planned sale
|
Rubenstein James H
Medical Director
Executive Director
Large shareholder
|
3,100
-0.3%
30.00
US$93,000
|
3,100
-0.3%
|
30.00
|
US$93,000
|
|
|
2006-10-10 |
2006-10-05 |
PlS
Planned sale
|
Dosoretz Daniel E
Chief Executive Officer
Executive Director
Large shareholder
|
5,500
-0.3%
30.00
US$165,000
|
5,500
-0.3%
|
30.00
|
US$165,000
|
|
|
2006-10-10 |
2006-10-05 |
PlS
Planned sale
|
Rubenstein James H
Medical Director
Executive Director
Large shareholder
|
5,500
-0.5%
30.00
US$165,000
|
5,500
-0.5%
|
30.00
|
US$165,000
|
|
|
2006-09-07 |
2006-09-05 |
PlS
Planned sale
|
Rubenstein James H
Medical Director
Executive Director
Large shareholder
|
10,000
-0.8%
29.80
US$298,038
|
10,000
-0.8%
|
29.80
|
US$298,038
|
|
|
2006-09-06 |
2006-09-05 |
PlS
Planned sale
|
Dosoretz Daniel E
Chief Executive Officer
Executive Director
Large shareholder
|
10,000
-0.5%
29.80
US$298,038
|
10,000
-0.5%
|
29.80
|
US$298,038
|
|
|
2006-09-07 |
2006-09-01 |
PlS
Planned sale
|
Rubenstein James H
Medical Director
Executive Director
Large shareholder
|
10,000
-0.8%
29.53
US$295,250
|
10,000
-0.8%
|
29.53
|
US$295,250
|
|
|
2006-09-06 |
2006-09-01 |
PlS
Planned sale
|
Dosoretz Daniel E
Chief Executive Officer
Executive Director
Large shareholder
|
10,000
-0.5%
29.53
US$295,250
|
10,000
-0.5%
|
29.53
|
US$295,250
|
|
|
2006-08-21 |
2006-08-18 |
PlS
Planned sale
|
Dosoretz Daniel E
Chief Executive Officer
Executive Director
Large shareholder
|
2,750
-0.1%
27.41
US$75,375
|
2,750
-0.1%
|
27.41
|
US$75,375
|
|
|
2006-08-21 |
2006-08-18 |
PlS
Planned sale
|
Rubenstein James H
Medical Director
Executive Director
Large shareholder
|
2,750
-0.2%
27.41
US$75,375
|
2,750
-0.2%
|
27.41
|
US$75,375
|
|
|
2006-08-21 |
2006-08-17 |
PlS
Planned sale
|
Dosoretz Daniel E
Chief Executive Officer
Executive Director
Large shareholder
|
7,250
-0.4%
27.50
US$199,379
|
7,250
-0.4%
|
27.50
|
US$199,379
|
|
|
2006-08-21 |
2006-08-17 |
PlS
Planned sale
|
Rubenstein James H
Medical Director
Executive Director
Large shareholder
|
7,250
-0.6%
27.50
US$199,379
|
7,250
-0.6%
|
27.50
|
US$199,379
|
|
|
2006-08-17 |
2006-08-15 |
PlS
Planned sale
|
Dosoretz Daniel E
Chief Executive Officer
Executive Director
Large shareholder
|
10,000
-0.5%
27.33
US$273,260
|
10,000
-0.5%
|
27.33
|
US$273,260
|
|
|
2006-08-17 |
2006-08-15 |
PlS
Planned sale
|
Rubenstein James H
Medical Director
Executive Director
Large shareholder
|
10,000
-0.8%
27.33
US$273,260
|
10,000
-0.8%
|
27.33
|
US$273,260
|
|
|
2006-07-12 |
2006-07-12 |
PlS
Planned sale
|
Dosoretz Daniel E
Chief Executive Officer
Executive Director
Large shareholder
|
9,000
-0.5%
26.94
US$242,424
|
9,000
-0.5%
|
26.94
|
US$242,424
|
|
|
2006-07-12 |
2006-07-12 |
PlS
Planned sale
|
Rubenstein James H
Medical Director
Executive Director
Large shareholder
|
9,000
-0.7%
26.94
US$242,424
|
9,000
-0.7%
|
26.94
|
US$242,424
|
|